Commonly-prescribed drug for IBD blunts COVID-19 vaccine response

By | April 26, 2021
People who take a commonly-prescribed drug for inflammatory bowel disease (IBD) should not assume they are protected after a first dose of COVID-19 vaccine, after a large-scale study found many had poor antibody responses.